Enhabit Earnings Reports

Enhabit, Inc. delivered a strong second quarter in 2025, with total net service revenue reaching $266.1 million, a 2.1% increase year-over-year. The company reported a net income of $5.2 million and an Adjusted EBITDA of $26.9 million, reflecting robust operational execution and strategic initiatives. Both home health and hospice segments contributed to this growth, with hospice showing particularly strong performance with a 19.4% increase in net service revenue and a 53.8% increase in Adjusted EBITDA.

Enhabit reported net service revenue of $259.9 million and net income attributable to Enhabit, Inc. of $17.8 million for Q1 2025. Adjusted EBITDA was $26.6 million, and adjusted diluted EPS was $0.10. The company highlighted sequential home health census growth, year-over-year hospice census growth, and improved leverage ratio.

Enhabit, Inc. reported positive fourth quarter results driven by strong growth in home health Medicare Advantage admissions, continued payor innovation success, and improved quality outcomes. Despite a slight decrease in total net service revenue, the company saw significant increases in non-episodic admissions and improved hospice cost efficiency.

Enhabit, Inc. reported a net service revenue of $260.6 million for Q2 2024, with a net loss attributable to Enhabit, Inc. of $0.2 million. The company achieved adjusted EBITDA of $25.2 million and adjusted EPS of $0.07, showing improvements in key metrics and continued progress in its growth strategies.

Enhabit, Inc. reported first-quarter 2024 financial results with total net service revenue of $262.4 million, a slight decrease from the previous year. Despite the revenue dip, the company maintained consolidated Adjusted EBITDA at $25.3 million, consistent with the prior year, primarily due to strong growth in home health Medicare Advantage admissions and effective cost control.

Enhabit, Inc. reported net service revenue of $275.1 million for the fourth quarter of 2022, a 0.4% decline from Q4 2021. Net income decreased by 72.5% to $8.2 million, and Adjusted EBITDA was down 17.8% to $40.3 million.